No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Market capitalization
300.07 MUSD
—
—
−1.12USD
−78.98 MUSD
62.37 MUSD
46.41 M
Beta (1Y)
0.85
About SOPHiA GENETICS SA
Sector
Industry
CEO
Jurgi Camblong
Website
Headquarters
Rolle
Employees (FY)
Founded
2011
ISIN
CH1125843347
FIGI
BBG011PFK7Q9
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
SOPH BullishThe 9ema crossed the the 20 ema and the most recent candle managed to close above the .23 fib level and also the 50 MA. The MACD and the Force Index are also rising. I would like to see the price hold the 50MA/.23 fib to establish support at that level and break out of its wedge. Target: 4.52
Long
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Featured
4.4Very Good
Learn more
TradeStation
4.5Great
Learn more
The current price of
SOPH
is
4.66
USD
— it has increased by
1.53
% in the past 24 hours. Watch
SOPHiA GENETICS SA
stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on
NASDAQ
exchange
SOPHiA GENETICS SA
stocks are traded under the ticker
SOPH
.
SOPH
stock has risen by
5.67
% compared to the previous week, the month change is a
6.61
% fall, over the last year
SOPHiA GENETICS SA
has showed a
6.15
% increase.
We've gathered analysts' opinions on
SOPHiA GENETICS SA
future price: according to them,
SOPH
price has a max estimate of
10.00
USD
and a min estimate of
6.00
USD
. Watch
SOPH chartand read a more detailed
SOPHiA GENETICS SA stock forecast: see what analysts think of
SOPHiA GENETICS SA
and suggest that you do with its stocks.
SOPH
reached its all-time high on
Sep 1, 2021
with the price of
19.80
USD
, and its all-time low was
1.69
USD
and was reached on
Nov 9, 2022
. View more price dynamics on
SOPH chart.
See other stocks reaching their highest and lowest prices.
SOPH
stock is
2.72
% volatile and has beta coefficient of
0.85
. Track
SOPHiA GENETICS SA
stock price on the chart and check out the list of the most volatile stocks — is
SOPHiA GENETICS SA
there?
Today
SOPHiA GENETICS SA
has the market capitalization of
300.07 M
, it has decreased by
5.11
% over the last week.
Yes, you can track
SOPHiA GENETICS SA financialsin yearly and quarterly reports right on TradingView.
SOPHiA GENETICS SA
is going to release the next earnings report on
Aug 6, 2024
. Keep track of upcoming events with our Earnings Calendar.
SOPH
earnings for the last quarter are
−0.21
USD
per share, whereas the estimation was
−0.25
USD
resulting in a
14.29
% surprise. The estimated earnings for the next quarter are
−0.27
USD
per share. See more details about
SOPHiA GENETICS SA earnings.
for the last quarter amounts to
15.78 M
USD
, despite the estimated figure of
16.45 M
USD
. In the next quarter, revenue is expected to reach
17.40 M
USD
.
SOPH
net income for the last quarter is
−13.70 M
USD
, while the quarter before that showed
−24.06 M
USD
of net income which accounts for
43.04
% change. Track more
SOPHiA GENETICS SA financial statsto get the full picture.
No,
SOPH
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of
Jul 3, 2024
, the company has
449.00
employees. See our rating of the largest employees — is
SOPHiA GENETICS SA
on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
SOPHiA GENETICS SA
EBITDA is
−66.73 M
USD
, and current EBITDA margin is
−109.94
%. See more stats in
SOPHiA GENETICS SA financial statements.
Like other stocks,
SOPH
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
SOPHiA GENETICS SA
stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
SOPHiA GENETICS SA
technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
SOPHiA GENETICS SA
stock shows the buy signal. See more of
SOPHiA GENETICS SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
